Media Newsroom of

Zensun USA, Inc.

Zensun USA, Inc.

Zensun USA, Inc., a wholly-owned subsidiary of Zensun Sci & Tech Co. Ltd., Shanghai. The company is a clinical-stage biopharmaceutical company with sites in China (Shanghai) and the USA (San Diego, CA).

Zensun Announces the Investigation of Neucardin for Chronic Heart Failure Receives Fast Track Designation From the US FDA

​​​​​​Zensun USA, Inc., a wholly-owned subsidiary of Zensun Sci & Tech Co. Ltd., Shanghai, announced that the investigation of NEUCARDIN®, its Recombinant human neuregulin-1 fragment, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login